It is reported that a nonsense or indel mutation of ARID1A was correlated with loss or reduction of protein expression in uterine endometrioid carcinoma, ovarian endometrioid carcinoma and clear cell carcinoma [11]–[13], [18]. Here, ARID1A is linked to endometrial endometrioid adenocarcinoma.